India's cheap weight-loss drugs could reshape global obesity fight
-
With India’s semaglutide patent expiring on 20 March, about 50 branded
generics are expected to enter the market.
1 hour ago
Posts
Tuesday, December 23, 2014
Subscribe to:
Post Comments (Atom)
Seed Newsvine
.jpg)
Pique: You Can’t Put A Label On Pope Francis http://foxrad.io/1x9OItm
ReplyDelete